Loma Linda, CALIFORNIA3 Active Studies

Multiple Sclerosis Clinical Trials in Loma Linda, CALIFORNIA

Find 3 actively recruiting multiple sclerosis clinical trials in Loma Linda, CALIFORNIA. Connect with local research sites and explore new treatment options.

3
Active Trials
2
Sponsors
2,106
Enrolling

Recruiting Multiple Sclerosis Studies in Loma Linda

About Multiple Sclerosis Clinical Trials in Loma Linda

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 3 multiple sclerosis clinical trials recruiting participants in Loma Linda, CALIFORNIA. These studies are seeking a combined 2,106 participants. Research is being sponsored by Children's Oncology Group, Celgene. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Loma Linda — FAQ

Are there multiple sclerosis clinical trials in Loma Linda?

Yes, there are 3 multiple sclerosis clinical trials currently recruiting in Loma Linda, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Loma Linda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Loma Linda research site will contact you about next steps.

Are clinical trials in Loma Linda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Loma Linda studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 3 active trials in Loma Linda are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated March 2, 2026 from ClinicalTrials.gov